In psoriasis, IL12B promotes pathogenic IL-23 signaling that drives Th17-mediated skin inflammation, whereas in AD, IL12B variation influences IL-12–dependent neuroinflammatory pathways and modulates susceptibility to cognitive decline. This evidence concerns the gene IL12B and dermatitis.